Needs a fresh review
State AG generic prescription drug price-fixing restitution
State attorneys general pursued price-fixing claims over generic prescription drugs and recovered money for consumers. The record does not name a court or the defendants, so the administrator's notice is the place to confirm those. This page explains who the consumer group is and how the funds are meant to be allocated.

Read the class definition and the case stage before deciding whether this notice concerns you.
Who the consumer group is
The group covers individuals who bought listed generic drugs in the US from May 1, 2009 through Dec 31, 2019, not for resale and not directly from a defendant. Defendant personnel are excluded. Eligibility depends on the current state of residence when claiming.
State-by-state differences
Residents of Louisiana and Missouri can claim, but with proportionately reduced recovery. Residents of Alabama, Arkansas, Hawaii and Texas can claim only as the site's plan specifies through class counsel's claims. Guam and American Samoa residents are not eligible.
What has been recovered
According to the administrator's FAQ, the States have recovered about $25 to $30 million in Consumer Restitution Funds so far, and more settlements are expected. Payment follows court approval of the distribution plan. Claims close March 8, 2027.
- Size
- Not established
- Potential
- Not establishedEstimated eligible claimants
- Difficulty
- Not established
The source check is older than seven days or the recorded deadline has been reached. Check the latest status with the official administrator.
- Topic
- Prescription drug price-fixing
- Country / coverage
- US · United States and territories
- Type of action
- Settlement claim
- Deadline
- Not currently verified
- Source eligibility conditions
- Individuals who bought one or more listed generic prescription drugs in the U.S. between May 1, 2009 and December 31, 2019, not for resale or directly from a defendant, who are not defendant personnel and who currently live in a U.S. state, commonwealth or territory other than Guam or American Samoa. Eligibility is based on current state of residence at the time of claiming. Residents of Louisiana and Missouri can claim but with proportionately reduced recovery; residents of Alabama, Arkansas, Hawaii and Texas can claim only as the site's plan specifies (class counsel's claims). A drug list is on the site.
- Proof requirements
- No receipts needed. Option 1 only requires certifying purchases; Option 2 asks for an estimate of total out-of-pocket spend and the administrator may later request documentation.
- Potential payment or benefit
- Administrator FAQ says about $25 to $30 million in Consumer Restitution Funds has been recovered so far and more settlements are expected. Option 1 is an equal share per settlement; Option 2 is a share by estimated spend. Individual amounts not stated. Paid by PayPal, Venmo, Zelle or check.
- Official source
- Read source
- Source checks
- 2026-10-12T15:45:00Z
2026-10-12T15:58:52Z
Why this record was included
Claims website (Rust Consulting), read 2026-10-12, accepts online and mailed claims to March 8, 2027.
Sources and verification notes
- aggenericdrugsclaims.com · 2026-10-12T15:30:00Z
Claims website states a March 8, 2027 claim deadline, the eligible consumer definition, no receipts for Option 1, and payment after court approval of the plan.
- aggenericdrugsclaims.com · 2026-10-12T15:30:00Z
Claim form page gives the online deadline as 11:59 p.m. PT on March 8, 2027 (postmark for mail) and describes Option 1 and Option 2.
- aggenericdrugsclaims.com · 2026-10-12T15:30:00Z
FAQ lists eligible states and territories and says about $25 to $30 million in Consumer Restitution Funds has been recovered by the States.
These records do not establish your individual eligibility or replace legal advice. Deadlines and benefits can change. This site does not file a claim.